VR
Venkata Ramana Manikumar Mynampati
About Venkata Ramana Manikumar Mynampati
Venkata Ramana Manikumar Mynampati has 8 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Ndx Pharma Labs Private Limited and Slim Infra Private Limited. Formerly with 1 company, such as Lorven Vetcare Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Ndx Pharma Labs Private Limited
U24304AP2018PTC108231
|
Managing Director | 20 Apr 2018 | 2018 | Active |
Slim Infra Private Limited
U45500AP2018PTC108127
|
Director | 10 Apr 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Lorven Vetcare Private Limited
U24304AP2018PTC107558
|
Director | 05 Feb 2018 | 2018 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Ramana Manikumar Mynampati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Ramana Manikumar Mynampati
Venkata Ramana Manikumar Mynampati has 8 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Ndx Pharma Labs Private Limited and Slim Infra Private Limited. Formerly with 1 company, such as Lorven Vetcare Private Limited. Engaged in General Business. Contributes to corporate operations.
Venkata Ramana Manikumar Mynampati is associated with 2 companies as Managing Director and Director.
Venkata Ramana Manikumar Mynampati has expertise in General Business.
Venkata Ramana Manikumar Mynampati has 8 years in corporate governance.